Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K250133
    Manufacturer
    Date Cleared
    2025-07-09

    (173 days)

    Product Code
    Regulation Number
    870.3300
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Nuvascular Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The HARBOR Occlusion Device is indicated for arterial embolization in the peripheral vasculature.

    Device Description

    The HARBOR Occlusion Device is a self-expanding braided nitinol arterial embolization implant (Figure 1) supplied with components used for implantation (Figure 2). The Device has a radiopaque marker band attached to the proximal end of the implant. The implant is packaged collapsed within an Introducer sheath and attached to a Delivery System provided within a hoop dispenser.

    AI/ML Overview

    The provided FDA 510(k) clearance letter and summary for the HARBOR Occlusion Device outlines the device's technical specifications and the testing performed to demonstrate its substantial equivalence to predicate devices, rather than a clinical study establishing performance criteria in relation to human interpretation or outcomes. Therefore, several requested sections (e.g., sample size for test set, data provenance, number of experts for ground truth, adjudication method, MRMC comparative effectiveness) are not applicable to the information provided.

    However, the document does detail the acceptance criteria (implicitly, "Pass" for each test) and the studies (bench and animal) that prove the device meets these criteria in the context of its substantial equivalence submission.

    Here's a breakdown of the available information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are implicitly "Pass" for each test listed, indicating that the device must perform acceptably in those areas to demonstrate substantial equivalence.

    Acceptance Criteria CategorySpecific TestReported Device Performance
    Implant Biocompatibility (ISO 10993-1)Medical Device Chemical Characterization and Extractables and Leachable for Compatibility of Materials (ISO 10993-18)In accordance with ISO 10993
    Implant Hemolysis TestIn accordance with ISO 10993
    Implant Complement Activation TestIn accordance with ISO 10993
    Toxicological Risk Assessment (ISO 10993-17)In accordance with ISO 10993
    Cytotoxicity (L929 MEM Elution Cytotoxicity Assay) (ISO 10993-5)In accordance with ISO 10993
    Sensitization (Kligman Maximization Sensitization in Guinea pigs with two extracts) (ISO 10993-10)In accordance with ISO 10993
    Irritation (Irritation/Intracutaneous Injection Reactivity) (ISO 10993-23)In accordance with ISO 10993
    Pyrogenicity (Material Mediated Rabbit Pyrogen) (ISO 10993-11)In accordance with ISO 10993
    Biocompatibility Evaluation Report (ISO10993-1)In accordance with ISO 10993
    Delivery System & Introducer Sheath Biocompatibility (ISO 10993-1)Cytotoxicity (L929 MEM Elution Cytotoxicity Assay) (ISO 10993-5)In accordance with ISO 10993
    Sensitization (Kligman Maximization Sensitization in Guinea pigs with two extracts) (ISO 10993-10)In accordance with ISO 10993
    Irritation (Irritation/Intracutaneous Injection Reactivity) (ISO 10993-23)In accordance with ISO 10993
    Systemic Toxicity (Acute Systemic Injection with two extracts) (ISO 10993-11)In accordance with ISO 10993
    Pyrogenicity (Material Mediated Rabbit Pyrogen) (ISO 10993-11)In accordance with ISO 10993
    Hemocompatibility (ASTM Hemolysis Complete, Indirect Contact) (ISO 10993-4)In accordance with ISO 10993
    Preclinical Mechanical, Visual, and Bench TestingVisual/Dimension InspectionPass
    Simulated Use (Preparation/Flush, Introduction, Tracking, Advancement, Kink Resistance, Flexibility, Microcatheter Compatibility, Deployment, Retraction, Detachment, Migration Resistance, Overall Performance)Pass
    Radial ForcePass
    Implant Tensile StrengthPass
    Joint Tensile StrengthPass
    Nickel Ion ReleasePass
    Corrosion ResistancePass
    Magnetic Resonance (MR) TestingPass
    RadiopacityPass
    Occlusion TimePass
    Shelf-Life Study (Products/Packaging)Pass
    PyrogenicityPass
    SterilityPass
    Packaging ValidationValidation per ASTM D4169, ASTM D4332, ASTM F88/F88M, ASTM F2096Pass
    Sterilization ValidationAchieved SAL of 10^-6Pass
    GLP Animal StudyEase of delivery (friction and tortuosity)Pass
    Acute ComplicationsPass
    Recanalization of the vessels/durability of occlusionPass
    Local and systemic foreign body reactionsPass
    Device migrationPass
    EffectivenessPass

    2. Sample size used for the test set and the data provenance

    Test Set Sample Size:

    • Bench Tests: Not explicitly stated for each test, but implied to be sufficient for meeting ISO and ASTM standards.
    • Animal Study: Not explicitly stated, but the study was described as "GLP Animal Study."

    Data Provenance: Not explicitly stated. The document refers to "pre-clinical testing" and "GLP animal study," which are typically conducted in a controlled laboratory environment but the country of origin is not specified. The studies are prospective in nature, as they were conducted specifically for this device's submission.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. This document describes the technical and biological performance of a medical device (an occlusion device) rather than an AI/CADe system or a diagnostic imaging device that would typically involve expert readers for establishing ground truth on image interpretation. The "acceptance criteria" here relate to the device's physical and biological functioning.

    4. Adjudication method for the test set

    Not applicable. As above, this is not a study assessing observer performance or diagnostic accuracy.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No. This document does not describe an AI-enabled device or an MRMC study. It pertains to a physical medical device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This describes a physical medical device, not an algorithm.

    7. The type of ground truth used

    The "ground truth" for the performance tests is established by:

    • Engineering specifications and standards: For bench testing (e.g., specific tensile strength values, radial force, dimensions, nickel ion release limits).
    • Biological responses: For biocompatibility tests (e.g., absence of cytotoxicity, irritation, sensitization, pyrogenicity, hemolysis, complement activation as per ISO 10993 standards).
    • Physiological and pathological observations in an animal model: For the GLP animal study (e.g., direct observation of delivery, acute complications, vessel recanalization, foreign body reactions, device migration, and effectiveness of occlusion).

    8. The sample size for the training set

    Not applicable. This device is not an AI/ML algorithm or system that requires a "training set."

    9. How the ground truth for the training set was established

    Not applicable. No training set exists for this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1